Hui Xiong
- Psychiatry and Mental health top 5%
- Hepatology top 10%
- Physiology top 10%
- Neurology top 10%
-
- Cancer-related molecular mechanisms research 6
- MicroRNA in disease regulation 4
-
- Pharmacological Receptor Mechanisms and Effects 3
- RNA modifications and cancer 3
- Bioinformatics and Genomic Networks 3
- Circular RNAs in diseases 3
-
- Cancer Immunotherapy and Biomarkers 3
-
- Photoreceptor and optogenetics research 2
- Co-authors
- Mark A. MintunNathaniel C. LimMichael NavitskyAnne McGeehanMichael D. DevousAbhinay D. JoshiAnupa AroraMichael J. Pontecorvo
- Partner nations
- ChinaUnited StatesHong Kong
In The Last Decade
Hui Xiong
47 papers receiving 1.1k citations
Peers
Comparison fields: 5 of 117
- Psychiatry and Mental health 260
- Hepatology 103
- Physiology 330
- Neurology 73
- Cancer Research 119
Countries citing papers authored by Hui Xiong
This map shows the geographic impact of Hui Xiong's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Hui Xiong with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Hui Xiong more than expected).
Fields of papers citing papers by Hui Xiong
This network shows the impact of papers produced by Hui Xiong. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Hui Xiong. The network helps show where Hui Xiong may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Hui Xiong, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 1 | |
| 2 | 2024 | 6 | |
| 3 | 2024 | 0 | |
| 4 | 2024 | 2 | |
| 5 | 2024 | 1 | |
| 6 | 2024 | 5 | |
| 7 | 2024 | 2 | |
| 8 | 2023 | 7 | |
| 9 | 2023 | 0 | |
| 10 | 2023 | 1 | |
| 11 | 2023 | 1 | |
| 12 | 2022 | 3 | |
| 13 | 2022 | 3 | |
| 14 | 2022 | 89 | |
| 15 | 2021 | 0 | |
| 16 | 2020 | 35 | |
| 17 | 2019 | 14 | |
| 18 | 2017 | 263 | |
| 19 | 2010 | 29 | |
| 20 | Transitive Closure and Metric Inequality of Weighted Graphs – Detecting Protein Interaction Modules Using Cliques | 2006 | 3 |
About Hui Xiong
Hui Xiong is a scholar working on Cancer Research, Applied Microbiology and Biotechnology and Molecular Biology, having authored 51 papers that have together received 1.2k indexed citations. Recurring topics across this work include Cancer-related molecular mechanisms research (6 papers), MicroRNA in disease regulation (4 papers), Pharmacological Receptor Mechanisms and Effects (3 papers), Cancer Immunotherapy and Biomarkers (3 papers), RNA modifications and cancer (3 papers), Bioinformatics and Genomic Networks (3 papers), Circular RNAs in diseases (3 papers) and Photoreceptor and optogenetics research (2 papers). The work is most often cited by research in Psychiatry and Mental health (260 citations), Hepatology (103 citations) and Physiology (330 citations). Hui Xiong has collaborated with scholars based in China, United States and Hong Kong. Frequent co-authors include Mark A. Mintun, Nathaniel C. Lim, Michael Navitsky, Anne McGeehan, Michael D. Devous, Abhinay D. Joshi, Anupa Arora, Michael J. Pontecorvo, Stephen Salloway and Frederick W. Schaerf. Their work appears in journals such as Journal of Clinical Oncology, PLoS ONE and Brain.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.